Company Profile
Oculis Stock Price, News & Analysis
- Ticker:
- OCS
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
13.15 USD (-3.52%)
Close
Last updated: July 13, 2026 at 00:00
823.09M USD
Market cap
Why the stock is moving
OCS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Oculis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Oculis is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Oculis follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Oculis sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Oculis (OCS)?
Oculis (OCS) most recently closed at 13.15 USD, a -3.52% move versus the previous session.
What is the market cap of Oculis (OCS)?
Oculis currently has a market capitalization of 823.09M USD on BioPharmSignal.
What does Oculis do?
Oculis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is OCS stock listed?
Oculis (OCS) is associated with NASDAQ, United States, Biotechnology.
What is Oculis?
Oculis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Oculis targeting with Oculis?
Oculis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.